Since, in the past, we showed that in preeclampsia cases there is a reduction in the expression of CD24, our results in this in-vitro model enable us to consider the reduced level of CD24 as an additional aspect of reduced immune tolerance in preeclampsia. This evidence concerns the gene CD24 and preeclampsia.